Comprehensive Stock Comparison
Compare Global Medical REIT Inc. (GMRE) vs Omega Healthcare Investors, Inc. (OHI) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | OHI | 10.7% revenue growth vs GMRE's -1.8% |
| Value | OHI | Lower P/E (24.3x vs 620.0x) |
| Quality / Margins | OHI | 50.2% net margin vs GMRE's 1.7% |
| Stability / Safety | OHI | Beta 0.10 vs GMRE's 0.58, lower leverage |
| Dividends | GMRE | 61.0% yield, 5-year raise streak, vs OHI's 5.3% |
| Momentum (1Y) | OHI | +38.3% vs GMRE's -8.0% |
| Efficiency (ROA) | OHI | 6.2% ROA vs GMRE's 0.2%, ROIC 5.7% vs 2.0% |
Who Each Stock Is For
Income & stability
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Defensive / Recession hedge
Business Model
What each company does and how it makes money
Global Medical REIT is a specialized real estate investment trust that acquires and leases purpose-built medical office buildings and healthcare facilities to leading healthcare providers. It generates revenue primarily through long-term triple-net leases—where tenants cover most property expenses—with its portfolio concentrated in medical office buildings (roughly 85% of assets) and inpatient rehabilitation hospitals. The company's competitive advantage lies in its specialized focus on mission-critical healthcare real estate—which tends to be recession-resistant—and its relationships with creditworthy healthcare systems that provide stable, long-term cash flows.
Omega Healthcare Investors is a real estate investment trust that owns and leases skilled nursing and assisted living facilities to healthcare operators. It generates revenue primarily through triple-net leases — where tenants pay rent plus property expenses — with skilled nursing facilities representing the majority of its portfolio. The company's moat lies in its specialized healthcare real estate expertise and diversified portfolio of essential healthcare properties across the US and UK.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Financial Metrics Comparison
Side-by-side fundamentals across 2 stocks. BestLagging
Financial Scorecard
OHI leads in 4 of 6 categories (Financial Metrics, Profitability & Efficiency). GMRE leads in 2 (Valuation Metrics, Analyst Outlook).
Financial Metrics (TTM)
OHI is the larger business by revenue, generating $1.2B annually — 8.0x GMRE's $148M. OHI is the more profitable business, keeping 50.2% of every revenue dollar as net income compared to GMRE's 1.7%. On growth, GMRE holds the edge at +18.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | GMREGlobal Medical RE… | OHIOmega Healthcare … |
|---|---|---|
| RevenueTrailing 12 months | $148M | $1.2B |
| EBITDAEarnings before interest/tax | $95M | $1.0B |
| Net IncomeAfter-tax profit | $2M | $597M |
| Free Cash FlowCash after capex | $19M | $629M |
| Gross MarginGross profit ÷ Revenue | +68.8% | +72.3% |
| Operating MarginEBIT ÷ Revenue | +24.9% | +60.2% |
| Net MarginNet income ÷ Revenue | +1.7% | +50.2% |
| FCF MarginFCF ÷ Revenue | +12.6% | +52.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +18.7% | +14.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -166.2% | +34.1% |
Valuation Metrics
At 31.1x trailing earnings, OHI trades at a 74% valuation discount to GMRE's 120.0x P/E. On an enterprise value basis, GMRE's 12.9x EV/EBITDA is more attractive than OHI's 18.5x.
| Metric | GMREGlobal Medical RE… | OHIOmega Healthcare … |
|---|---|---|
| Market CapShares × price | $499M | $13.5B |
| Enterprise ValueMkt cap + debt − cash | $1.1B | $17.8B |
| Trailing P/EPrice ÷ TTM EPS | 120.00x | 31.14x |
| Forward P/EPrice ÷ next-FY EPS est. | 620.00x | 24.31x |
| PEG RatioP/E ÷ EPS growth rate | — | 187.73x |
| EV / EBITDAEnterprise value multiple | 12.91x | 18.45x |
| Price / SalesMarket cap ÷ Revenue | 3.60x | 12.81x |
| Price / BookPrice ÷ Book value/share | 0.18x | 2.76x |
| Price / FCFMarket cap ÷ FCF | — | 17.98x |
Profitability & Efficiency
OHI delivers a 11.0% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $0 for GMRE. OHI carries lower financial leverage with a 1.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to GMRE's 1.18x. On the Piotroski fundamental quality scale (0–9), OHI scores 8/9 vs GMRE's 4/9, reflecting strong financial health.
| Metric | GMREGlobal Medical RE… | OHIOmega Healthcare … |
|---|---|---|
| ROE (TTM)Return on equity | +0.5% | +11.0% |
| ROA (TTM)Return on assets | +0.2% | +6.2% |
| ROICReturn on invested capital | +2.0% | +5.7% |
| ROCEReturn on capital employed | +5.3% | +7.2% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 8 |
| Debt / EquityFinancial leverage | 1.18x | 1.02x |
| Net DebtTotal debt minus cash | $647M | $4.3B |
| Cash & Equiv.Liquid assets | $7M | $518M |
| Total DebtShort + long-term debt | $654M | $4.8B |
| Interest CoverageEBIT ÷ Interest expense | 1.14x | 2.98x |
Total Returns (with DRIP)
A $10,000 investment in OHI five years ago would be worth $16,302 today (with dividends reinvested), compared to $8,626 for GMRE. Over the past 12 months, OHI leads with a +38.3% total return vs GMRE's -8.0%. The 3-year compound annual growth rate (CAGR) favors OHI at 28.1% vs GMRE's -0.9% — a key indicator of consistent wealth creation.
| Metric | GMREGlobal Medical RE… | OHIOmega Healthcare … |
|---|---|---|
| YTD ReturnYear-to-date | +9.8% | +9.9% |
| 1-Year ReturnPast 12 months | -8.0% | +38.3% |
| 3-Year ReturnCumulative with dividends | -2.8% | +110.2% |
| 5-Year ReturnCumulative with dividends | -13.7% | +63.0% |
| 10-Year ReturnCumulative with dividends | +319.0% | +132.8% |
| CAGR (3Y)Annualised 3-year return | -0.9% | +28.1% |
Risk & Volatility
OHI is the less volatile stock with a 0.10 beta — it tends to amplify market swings less than GMRE's 0.58 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. OHI currently trades 98.2% from its 52-week high vs GMRE's 81.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | GMREGlobal Medical RE… | OHIOmega Healthcare … |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.58x | 0.10x |
| 52-Week HighHighest price in past year | $45.75 | $49.14 |
| 52-Week LowLowest price in past year | $29.05 | $35.04 |
| % of 52W HighCurrent price vs 52-week peak | +81.3% | +98.2% |
| RSI (14)Momentum oscillator 0–100 | 53.8 | 68.6 |
| Avg Volume (50D)Average daily shares traded | 72K | 1.6M |
Analyst Outlook
Wall Street rates GMRE as "Buy" and OHI as "Hold". Consensus price targets imply 7.5% upside for GMRE (target: $40) vs 1.8% for OHI (target: $49). For income investors, GMRE offers the higher dividend yield at 61.02% vs OHI's 5.25%.
| Metric | GMREGlobal Medical RE… | OHIOmega Healthcare … |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $40.00 | $49.14 |
| # AnalystsCovering analysts | 22 | 28 |
| Dividend YieldAnnual dividend ÷ price | +61.0% | +5.3% |
| Dividend StreakConsecutive years of raises | 5 | 0 |
| Dividend / ShareAnnual DPS | $22.70 | $2.53 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | Feb 20 | Feb 26 | Change |
|---|---|---|---|
| Global Medical REIT… (GMRE) | 100 | 49.79 | -50.2% |
| Omega Healthcare In… (OHI) | 100 | 108.64 | +8.6% |
Omega Healthcare In… (OHI) returned +63% over 5 years vs Global Medical REIT… (GMRE)'s -14%. A $10,000 investment in OHI 5 years ago would be worth $16,302 today (including dividends reinvested).
Chart 2Revenue Growth — 10 Years
| Stock | 2015 | 2024 | Change |
|---|---|---|---|
| Global Medical REIT… (GMRE) | $2M | $138M | +6613.5% |
| Omega Healthcare In… (OHI) | $744M | $1.1B | +41.4% |
Global Medical REIT Inc.'s revenue grew from $2M (2015) to $138M (2024) — a 59.6% CAGR. Omega Healthcare Investors, Inc.'s revenue grew from $744M (2015) to $1.1B (2024) — a 3.9% CAGR.
Chart 3Net Margin Trend — 10 Years
| Stock | 2015 | 2024 | Change |
|---|---|---|---|
| Global Medical REIT… (GMRE) | -78.1% | 4.8% | +106.1% |
| Omega Healthcare In… (OHI) | 30.2% | 38.6% | +28.0% |
Global Medical REIT Inc.'s net margin went from -78% (2015) to 5% (2024). Omega Healthcare Investors, Inc.'s net margin went from 30% (2015) to 39% (2024).
Chart 4P/E Ratio History — 8 Years
| Stock | 2017 | 2024 | Change |
|---|---|---|---|
| Global Medical REIT… (GMRE) | 2.9 | 124.5 | +4193.1% |
| Omega Healthcare In… (OHI) | 54 | 24.4 | -54.8% |
Global Medical REIT Inc. has traded in a 3x–125x P/E range over 3 years; current trailing P/E is ~120x. Omega Healthcare Investors, Inc. has traded in a 16x–54x P/E range over 8 years; current trailing P/E is ~31x.
Chart 5EPS Growth — 10 Years
| Stock | 2015 | 2024 | Change |
|---|---|---|---|
| Global Medical REIT… (GMRE) | -161 | 0.31 | +100.2% |
| Omega Healthcare In… (OHI) | 1.29 | 1.55 | +20.2% |
Global Medical REIT Inc.'s EPS grew from $-161.00 (2015) to $0.31 (2024). Omega Healthcare Investors, Inc.'s EPS grew from $1.29 (2015) to $1.55 (2024) — a 2% CAGR.
Chart 6Free Cash Flow — 5 Years
Global Medical REIT Inc. generated $-25M FCF in 2024 (+81% vs 2021). Omega Healthcare Investors, Inc. generated $749M FCF in 2024 (+20% vs 2021).
GMRE vs OHI: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is GMRE or OHI a better buy right now?
Omega Healthcare Investors, Inc. (OHI) offers the better valuation at 31.1x trailing P/E (24.3x forward), making it the more compelling value choice. Analysts rate Global Medical REIT Inc. (GMRE) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — GMRE or OHI?
On trailing P/E, Omega Healthcare Investors, Inc. (OHI) is the cheapest at 31.1x versus Global Medical REIT Inc. at 120.0x. On forward P/E, Omega Healthcare Investors, Inc. is actually cheaper at 24.3x.
03Which is the better long-term investment — GMRE or OHI?
Over the past 5 years, Omega Healthcare Investors, Inc. (OHI) delivered a total return of +63.0%, compared to -13.7% for Global Medical REIT Inc. (GMRE). A $10,000 investment in OHI five years ago would be worth approximately $16K today (assuming dividends reinvested). Over 10 years, the gap is even starker: GMRE returned +319.0% versus OHI's +132.8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — GMRE or OHI?
By beta (market sensitivity over 5 years), Omega Healthcare Investors, Inc. (OHI) is the lower-risk stock at 0.10β versus Global Medical REIT Inc.'s 0.58β — meaning GMRE is approximately 496% more volatile than OHI relative to the S&P 500. On balance sheet safety, Omega Healthcare Investors, Inc. (OHI) carries a lower debt/equity ratio of 102% versus 118% for Global Medical REIT Inc. — giving it more financial flexibility in a downturn.
05Which has better profit margins — GMRE or OHI?
Omega Healthcare Investors, Inc. (OHI) is the more profitable company, earning 38.6% net margin versus 4.8% for Global Medical REIT Inc. — meaning it keeps 38.6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OHI leads at 62.7% versus 23.6% for GMRE. At the gross margin level — before operating expenses — OHI leads at 98.6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is GMRE or OHI more undervalued right now?
On forward earnings alone, Omega Healthcare Investors, Inc. (OHI) trades at 24.3x forward P/E versus 620.0x for Global Medical REIT Inc. — 595.7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GMRE: 7.5% to $40.00.
07Which pays a better dividend — GMRE or OHI?
All stocks in this comparison pay dividends. Global Medical REIT Inc. (GMRE) offers the highest yield at 61.0%, versus 5.3% for Omega Healthcare Investors, Inc. (OHI).
08Is GMRE or OHI better for a retirement portfolio?
For long-horizon retirement investors, Omega Healthcare Investors, Inc. (OHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.10), 5.3% yield, +132.8% 10Y return). Both have compounded well over 10 years (OHI: +132.8%, GMRE: +319.0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between GMRE and OHI?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.